Taipei Exchange - Delayed Quote TWD

Bioray Biotech Co., Ltd (7561.TWO)

Compare
21.60
+0.25
+(1.17%)
At close: 1:52:17 PM GMT+8
Currency in TWD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
191,830.00
191,830.00
190,597.00
148,018.00
156,295.00
Cost of Revenue
114,179.00
114,179.00
110,087.00
80,728.00
88,436.00
Gross Profit
77,651.00
77,651.00
80,510.00
67,290.00
67,859.00
Operating Expense
96,996.00
96,996.00
80,745.00
75,403.00
67,768.00
Operating Income
-19,345.00
-19,345.00
-235.00
-8,113.00
91.00
Net Non Operating Interest Income Expense
-673.00
-673.00
-1,173.00
-900.00
-1,038.00
Pretax Income
-14,189.00
-14,189.00
682.00
-6,171.00
-1,455.00
Tax Provision
-2,630.00
-2,630.00
182.00
1,763.00
-42.00
Net Income Common Stockholders
-11,559.00
-11,559.00
500.00
-7,191.00
-58.00
Diluted NI Available to Com Stockholders
-11,559.00
-11,559.00
500.00
-7,191.00
-58.00
Basic EPS
-0.38
--
0.02
-0.27
-0.00
Diluted EPS
-0.38
--
0.02
-0.27
-0.00
Basic Average Shares
30,085.00
--
28,019.00
26,770.00
27,414.00
Diluted Average Shares
30,085.00
--
28,019.00
26,770.00
27,415.03
Total Expenses
211,175.00
211,175.00
190,832.00
156,131.00
156,204.00
Net Income from Continuing & Discontinued Operation
-11,559.00
-11,559.00
500.00
-7,191.00
-58.00
Normalized Income
-11,570.41
-11,570.41
557.18
-7,191.00
245.96
Interest Income
648.00
648.00
191.00
53.00
135.00
Interest Expense
1,321.00
1,321.00
1,364.00
953.00
1,173.00
Net Interest Income
-673.00
-673.00
-1,173.00
-900.00
-1,038.00
EBIT
-12,868.00
-12,868.00
2,046.00
-5,218.00
-282.00
EBITDA
12,135.00
12,135.00
24,275.00
13,862.00
14,993.00
Reconciled Cost of Revenue
114,179.00
114,179.00
110,087.00
80,728.00
88,436.00
Reconciled Depreciation
25,003.00
25,003.00
22,229.00
19,080.00
15,275.00
Net Income from Continuing Operation Net Minority Interest
-11,559.00
-11,559.00
500.00
-7,191.00
-58.00
Total Unusual Items Excluding Goodwill
14.00
14.00
-78.00
--
-313.00
Total Unusual Items
14.00
14.00
-78.00
--
-313.00
Normalized EBITDA
12,121.00
12,121.00
24,353.00
13,862.00
15,306.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
2.59
2.59
-20.82
--
-9.04
12/31/2020 - 7/27/2020

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

6621.TWO UniPharma Co., Ltd.
14.15
+0.35%
 
1780.TWO Allied Biotech Corporation
17.10
+0.29%
 
6677.TWO Anxo Pharmaceutical Co., Ltd.
25.50
+0.20%
 
6467.TWO TAHO Pharma
48.80
-2.79%
 
6496.TWO Excelsior Biopharma Inc.
31.25
-2.34%
 
4166.TWO Orient Pharma Co., Ltd.
38.35
-3.03%
 
4117.TWO General Biologicals Corporation
18.50
-3.14%
 
4172.TWO InnoPharmax Inc.
16.20
-1.22%
 
4132.TWO Golden Biotechnology Corporation
17.80
-0.56%
 
4747.TWO Johnson Chemical Pharmaceutical Works Co., Ltd.
71.50
-1.65%